Wire Stories

Uniper, Hydrogenious of Germany and JERA Americas to Partner with ADNOC to Explore Hydrogen Opportunities

Companies to jointly study hydrogen transportation between the United Arab Emirates (UAE) and Germany using…

Data443 to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest

Ransomware Recovery, Data Privacy, and Recent Customer Wins, Including Emirates NBD to be Discussed RESEARCH…

Gilat’s Electronically Steerable Antenna (ESA) for IFC Achieves Breakthrough During Airbus Flight Tests Operating on Spacecom’s Advanced Satellite

Gilat's fully-integrated ESA technology is proven to be at the forefront of the next-generation ESA…

Liquidia Corporation Reports Full-Year 2021 Financial Results and Provides Corporate Update

- Received tentative FDA approval of YUTREPIA™ (treprostinil) inhalation powder - Expanded use of Treprostinil Injection to…

Radware Expands its Partnership with Presidio

Presidio to offer Radware’s Cloud Native Protector, application security, and DDoS protection solutions MAHWAH, N.J.…

FPT Software Achieves HITRUST Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance

HITRUST Risk-based, 2-year Certification validates FPT Software's commitment to meeting key regulations and protecting sensitive…

OneConnect Announces Share Purchase by Ping An Group

SHENZHEN, China--(BUSINESS WIRE)--OneConnect Financial Technology Co., Ltd. (“OneConnect” or the “Company”) (NYSE: OCFT), a leading…

Vedanta Aluminium Launches ‘Restora’, First Low Carbon ‘Green’ Aluminium from India

NEW DELHI--(BUSINESS WIRE)--#AnnanyaAgarwal--Vedanta Aluminium, India’s largest producer of aluminium and value-added products, launches ‘Restora’, its…

Canterbury Park Holding Corporation Reports Record 2021 Fourth Quarter Results

SHAKOPEE, Minn., March 21, 2022 (GLOBE NEWSWIRE) -- Canterbury Park Holding Corporation (“Canterbury” or the…

Zai Lab Presents Positive Results from Phase 3 PRIME Study of ZEJULA® (Niraparib) at Society of Gynecologic Oncology Meeting

PRIME study demonstrates that niraparib treatment had a statistically significant and clinically meaningful improvement in progression-free survival…